Progesterone(P) antibody/antigen (BSA/OVA/KLH conjugated hapten)

anti-Progesterone(P) antibody and Carrier-coupled antigen/immunogen (hapten-carrier conjugates)

Target products collectionGo to Hormones diagnostics products collection >>


Product information

Catalog No.DescriptionUS $ Price (per mg)
GMP-SMT-182-11. BSA-Progesterone(P)
2. Anti-Progesterone(P) mouse monoclonal antibody
$2709.00
GMP-SMT-182-21. OVA-Progesterone(P)
2. Anti-Progesterone(P) mouse monoclonal antibody
$2709.00
GMP-SMT-182-31. BSA-Progesterone(P)
2. Anti-Progesterone(P) human monoclonal antibody
$2709.00
GMP-SMT-182-41. OVA-Progesterone(P)
2. Anti-Progesterone(P) human monoclonal antibody
$2709.00
GMP-SMT-182-Ag-1BSA-Progesterone(P)$756.00
GMP-SMT-182-Ag-2OVA-Progesterone(P)$756.00
GMP-SMT-182-Ab-1Anti-Progesterone(P) mouse monoclonal antibody$1953.00
GMP-SMT-182-Ab-2Anti-Progesterone(P) human monoclonal antibody$1953.00

Size: 1mg | 10mg | 100mg



Product Description


BSA-Progesterone(P)

Cat No.GMP-SMT-182-Ag-1
Bioactivity validationCompetitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody;
Products descriptionCompetitive immunoassay-validated hapten-carrier conjugates BSA-Progesterone(P) with anti-Hapten antibody. The hapten hapten-carrier conjugates BSA-Progesterone(P) had been validated with our anti-Hapten antibody Anti-Progesterone(P) mouse monoclonal antibody via competitive ELISA test.
ApplicationELISA tests and other immunoassays;
Lateral flow immunoassay (LFIA);
LTIA
Immunonephelometry
Time-resolved Fluorescence Immunoassay (TRFIA)
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


OVA-Progesterone(P)

Cat No.GMP-SMT-182-Ag-2
Bioactivity validationCompetitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody;
Products descriptionCompetitive immunoassay-validated hapten-carrier conjugates OVA-Progesterone(P) with anti-Hapten antibody. The hapten hapten-carrier conjugates OVA-Progesterone(P) had been validated with our anti-Hapten antibody Anti-Progesterone(P) mouse monoclonal antibody via competitive ELISA test.
ApplicationELISA tests and other immunoassays;
Lateral flow immunoassay (LFIA);
LTIA
Immunonephelometry
Time-resolved Fluorescence Immunoassay (TRFIA)
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Anti-Progesterone(P) mouse monoclonal antibody

Cat No.GMP-SMT-182-Ab-1
Host of AntibodyMouse IgG
Bioactivity validationCompetitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody;
Lateral flow immunoassay (LFIA);
ELISA IC50 (ppb)0.25-0.5
Products descriptionThe anti-Hapten antibody against hapten Progesterone(P) had been validated with our hapten hapten-carrier conjugates BSA-Progesterone(P) via competitive ELISA test.
ApplicationELISA tests and other immunoassays;
Lateral flow immunoassay (LFIA);
LTIA
Immunonephelometry
Time-resolved Fluorescence Immunoassay (TRFIA)
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Anti-Progesterone(P) human monoclonal antibody

Cat No.GMP-SMT-182-Ab-2
Host of AntibodyHuman IgG1
Bioactivity validationCompetitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody;
Lateral flow immunoassay (LFIA);
ELISA IC50 (ppb)0.25-0.5
Products descriptionThe anti-Hapten antibody against hapten Progesterone(P) had been validated with our hapten hapten-carrier conjugates BSA-Progesterone(P) via competitive ELISA test.
ApplicationELISA tests and other immunoassays;
Lateral flow immunoassay (LFIA);
LTIA
Immunonephelometry
Time-resolved Fluorescence Immunoassay (TRFIA)
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Biomarker Information


    1. Progesterone (P) and Its Significance in In Vitro Diagnosis

    1.1 What is Progesterone (P)?

    Progesterone (P) is a small molecule of immense importance, categorized as a steroid hormone. Within the context of in vitro diagnostics, Progesterone assumes a pivotal role, primarily associated with the female reproductive system. This hormone is essential for the preparation and maintenance of the uterine lining, known as the endometrium, a critical aspect of the reproductive process.

    1.2 Role in In Vitro Diagnosis

    In vitro diagnostics harness the power of Progesterone (P) as a potent biomarker, contributing to an array of vital applications:

    a. Menstrual Cycle Monitoring: Progesterone (P) measurement plays a pivotal role in tracking the menstrual cycle, providing a precise assessment of ovulation and the luteal phase. This knowledge is foundational for fertility assessment, aiding couples in family planning endeavors.

    b. Fertility Evaluation: The precise evaluation of Progesterone levels is instrumental in assessing fertility, especially in cases where ovulatory disorders are suspected. Monitoring the fluctuations in Progesterone levels enables healthcare providers to pinpoint the optimal timing for conception.

    c. Pregnancy Confirmation and Monitoring: Progesterone holds a critical position in pregnancy by supporting the uterine environment, facilitating embryonic development. Its measurement is not only crucial for confirming pregnancy but also for the ongoing monitoring of Progesterone levels throughout gestation. This is particularly significant in high-risk pregnancies where maintaining adequate Progesterone levels is essential.

    d. Hormone Replacement Therapy (HRT): Hormone Replacement Therapy is a common approach for menopausal women and individuals dealing with hormonal imbalances. Progesterone measurement is pivotal in tailoring HRT regimens to the unique needs of patients, ensuring precise hormonal balance and symptom alleviation.

    e. Reproductive Disorder Diagnosis: Progesterone assessment is invaluable for diagnosing and managing reproductive disorders such as Polycystic Ovary Syndrome (PCOS) and amenorrhea. Deviations from normative Progesterone levels provide vital diagnostic insights and inform treatment strategies.

    1.3 The Role of Progesterone in Reproductive Health

    Understanding the significance of Progesterone in reproductive health requires a deeper dive into its mechanisms:

    a. Luteal Phase Support: Progesterone is often referred to as the "hormone of pregnancy." During the menstrual cycle, it dominates the luteal phase, fostering the thickening of the endometrial lining. This creates a nourishing environment for a potential embryo to implant and develop.

    b. Fertility Window: Progesterone surge indicates the occurrence of ovulation, marking the fertility window for women. Precise Progesterone measurement assists couples in optimizing their chances of conception.

    c. Pregnancy Maintenance: Once conception occurs, Progesterone continues to play a vital role. It supports the uterine environment, preventing the shedding of the endometrial lining and ensuring the embryo's stable implantation and growth.

    d. HRT Balance: Hormone Replacement Therapy, often prescribed during menopause, includes Progesterone to balance estrogen effects. Proper Progesterone levels mitigate the risk of endometrial hyperplasia and cancer associated with unopposed estrogen.

    e. Disorder Diagnosis: Reproductive disorders such as PCOS, characterized by irregular ovulation, are identified through Progesterone assessment. Low Progesterone levels may signal amenorrhea or anovulation, prompting further evaluation and treatment.

    1.4 The Clinical Significance of Progesterone Measurement

    In a clinical setting, Progesterone measurement is executed through various methods, including blood tests, urine tests, and saliva tests. These approaches offer healthcare providers a comprehensive view of hormonal fluctuations, enabling them to make informed decisions regarding patient care.

    1.5 Conclusion

    The measurement of Progesterone (P) serves as a linchpin in in vitro diagnostics, providing a window into reproductive health, fertility assessment, pregnancy confirmation, hormone replacement therapy management, and the diagnosis of reproductive disorders. The precision and accuracy of Progesterone quantification empower healthcare professionals and researchers to make well-informed decisions, enhancing patient care and propelling the field of women's health and fertility towards ever greater advancements.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.